News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,906 Results
Type
Article (23304)
Company Profile (33)
Press Release (355568)
Multimedia
Podcasts (117)
Webinars (13)
Section
Business (119445)
Career Advice (1448)
Deals (17547)
Drug Delivery (66)
Drug Development (42414)
Employer Resources (101)
FDA (8811)
Job Trends (8465)
News (190941)
Policy (17244)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1492)
Academic (1)
Accelerated approval (17)
Adcomms (15)
Allergies (93)
Alliances (33237)
ALS (108)
Alzheimer's disease (988)
Antibody-drug conjugate (ADC) (189)
Approvals (9050)
Artificial intelligence (349)
Autoimmune disease (102)
Automation (27)
Bankruptcy (159)
Best Places to Work (7054)
BIOSECURE Act (6)
Biosimilars (112)
Biotechnology (26)
Bladder cancer (113)
Brain cancer (34)
Breast cancer (418)
Cancer (3188)
Cardiovascular disease (269)
Career advice (1249)
Career pathing (30)
CAR-T (148)
CDC (24)
Cell therapy (467)
Cervical cancer (24)
Clinical research (36706)
Collaboration (1299)
Company closure (1)
Compensation (289)
Complete response letters (27)
COVID-19 (1521)
CRISPR (61)
C-suite (454)
Cystic fibrosis (80)
Data (4326)
Decentralized trials (2)
Denatured (41)
Depression (83)
Diabetes (340)
Diagnostics (3592)
Digital health (29)
Diversity (7)
Diversity, equity & inclusion (33)
Drug discovery (176)
Drug pricing (96)
Drug shortages (20)
Duchenne muscular dystrophy (152)
Earnings (58139)
Editorial (44)
Employer branding (12)
Employer resources (89)
Events (57406)
Executive appointments (544)
FDA (10857)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (6)
Frontotemporal dementia (17)
Funding (846)
Gene editing (130)
Generative AI (39)
Gene therapy (412)
GLP-1 (593)
Government (2407)
Grass and pollen (7)
Guidances (322)
Healthcare (10310)
HIV (46)
Huntington's disease (29)
IgA nephropathy (58)
Immunology and inflammation (149)
Immuno-oncology (37)
Indications (86)
Infectious disease (1668)
Inflammatory bowel disease (123)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (154)
Interviews (270)
IPO (8421)
IRA (31)
Job creations (1729)
Job search strategy (1013)
JPM (46)
Kidney cancer (8)
Labor market (50)
Layoffs (251)
Leadership (29)
Legal (4434)
Liver cancer (45)
Longevity (9)
Lung cancer (440)
Lymphoma (272)
Machine learning (24)
Management (34)
Manufacturing (493)
MASH (122)
Medical device (6846)
Medtech (6878)
Mergers & acquisitions (9826)
Metabolic disorders (831)
Multiple sclerosis (113)
NASH (9)
Neurodegenerative disease (187)
Neuropsychiatric disorders (51)
Neuroscience (1739)
NextGen: Class of 2026 (3435)
Non-profit (2772)
Now hiring (9)
Obesity (361)
Opinion (198)
Ovarian cancer (92)
Pain (118)
Pancreatic cancer (138)
Parkinson's disease (166)
Partnered (22)
Patents (294)
Patient recruitment (250)
Peanut (29)
People (28181)
Pharmaceutical (11)
Pharmacy benefit managers (15)
Phase 1 (11015)
Phase 2 (15598)
Phase 3 (13107)
Pipeline (3941)
Policy (164)
Postmarket research (1648)
Preclinical (4819)
Press Release (31)
Prostate cancer (203)
Psychedelics (28)
Radiopharmaceuticals (169)
Rare diseases (546)
Real estate (2580)
Recruiting (38)
Regulatory (13034)
Reports (21)
Research institute (1391)
Resumes & cover letters (220)
Rett syndrome (20)
RNA editing (10)
RSV (42)
Schizophrenia (96)
Series A (149)
Series B (97)
Service/supplier (3)
Sickle cell disease (68)
Special edition (13)
Spinal muscular atrophy (76)
Sponsored (27)
Startups (1531)
State (1)
Stomach cancer (10)
Supply chain (54)
Tariffs (38)
The Weekly (75)
Vaccines (595)
Venture capital (49)
Weight loss (224)
Women's health (54)
Worklife (14)
Date
Today (32)
Last 7 days (401)
Last 30 days (1292)
Last 365 days (18984)
2026 (2159)
2025 (19073)
2024 (20322)
2023 (22339)
2022 (28272)
2021 (30065)
2020 (29419)
2019 (25333)
2018 (18710)
2017 (17577)
2016 (17138)
2015 (19460)
2014 (16328)
2013 (14266)
2012 (14088)
2011 (13550)
2010 (12780)
Location
Africa (546)
Alabama (58)
Alaska (4)
Arizona (130)
Arkansas (7)
Asia (22078)
Australia (3614)
California (6623)
Canada (2031)
China (668)
Colorado (336)
Connecticut (340)
Delaware (210)
Europe (52037)
Florida (1101)
Georgia (224)
Hawaii (1)
Idaho (23)
Illinois (498)
India (48)
Indiana (365)
Iowa (10)
Japan (296)
Kansas (73)
Kentucky (16)
Louisiana (9)
Maine (37)
Maryland (836)
Massachusetts (4855)
Michigan (205)
Minnesota (297)
Mississippi (1)
Missouri (56)
Montana (12)
Nebraska (9)
Nevada (76)
New Hampshire (35)
New Jersey (2131)
New Mexico (14)
New York (1890)
North Carolina (896)
North Dakota (5)
Northern California (3186)
Ohio (169)
Oklahoma (14)
Oregon (19)
Pennsylvania (1436)
Puerto Rico (7)
Rhode Island (26)
South America (761)
South Carolina (30)
Southern California (2690)
Tennessee (121)
Texas (1033)
United States (24344)
Utah (217)
Vermont (1)
Virginia (147)
Washington D.C. (52)
Washington State (542)
West Virginia (2)
Wisconsin (58)
Wyoming (2)
378,906 Results for "owens and minor".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Owens & Minor Reports First Quarter 2024 Financial Results
Owens & Minor, Inc. reported financial results for the first quarter ended March 31, 2024.
May 3, 2024
·
18 min read
Business
Owens & Minor Announces First Quarter 2024 Earnings Release Date and Conference Call
Owens & Minor, Inc. plans to release financial results for the first quarter of 2024 on Friday, May 3, 2024, before trading begins on the New York Stock Exchange.
April 22, 2024
·
1 min read
Business
Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results
Owens & Minor, Inc. reported financial results for the fourth quarter and year ended December 31, 2023.
February 20, 2024
·
24 min read
Press Releases
HepaRegeniX Completes Phase Ib Study of HRX-215 to Enhance Liver Regeneration in Patients Undergoing Minor Liver Resection
February 11, 2026
·
4 min read
Press Releases
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
February 10, 2026
·
4 min read
BioCapital
Owens & Minor Launches Life Takes Care™
Owens & Minor, Inc. has unveiled its new purpose, Life Takes Care. More than a motto or tagline, Life Takes Care captures the company’s unique approach to caring for both the business and the humanity at the heart of healthcare.
December 7, 2023
·
2 min read
BioCapital
Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024
Owens & Minor, Inc. announced that Alex Bruni, the Company’s Executive Vice President and Chief Financial Officer and Jonathan Leon, the Company’s Senior Vice President-Finance and Corporate Treasurer, will be participating in a webcasted fireside chat at 5:20 p.m. Eastern Daylight Time on Wednesday, May 15, 2024 at BofA Securities’ 2024 Health Care Conference in Las Vegas, Nevada.
May 13, 2024
·
1 min read
Press Releases
Owens & Minor Reports Third Quarter 2024 Financial Results
November 5, 2024
·
18 min read
BioCapital
The Owens & Minor Foundation Provides Update on ESG Initiatives and Teammate Engagement
The Owens & Minor Foundation shared its achievements over the past year in delivering on its efforts to help build healthier communities.
September 27, 2023
·
3 min read
Business
Owens & Minor Reports Second Quarter 2023 Financial Results
Owens & Minor, Inc. reported financial results for the second quarter ended June 30, 2023.
August 4, 2023
·
23 min read
1 of 37,891
Next
